Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Recruiting × Selective Estrogen Receptor Modulators × Clear all

Phase

Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Advanced Breast Cancer 1

Interventions

Carboplatin 99 Cisplatin 97 pembrolizumab 90 Gemcitabine 82 Paclitaxel 79 Docetaxel 71 Capecitabine 58 Oxaliplatin 53 Fluorouracil 52 Specimen Handling 51 Bevacizumab 51 Radiotherapy 50 Magnetic Resonance Spectroscopy 48 Dexamethasone 44 Cyclophosphamide 43 Leucovorin 40 Pemetrexed 39 Drug Therapy 39 Irinotecan 38 Doxorubicin 37 Injections 31 Rituximab 29 Vincristine 26 Trastuzumab 26 Lenalidomide 26 Etoposide 26 Radiosurgery 25 130-nm albumin-bound paclitaxel 25 Radiation 24 Prednisone 24

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06382948 2026-04-03

ADELA

MedSIR

Phase 3 Recruiting

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡